Medical Care

Global Anti-CD45 Antibody Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Anti-CD45 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-CD45 Antibody.
The Anti-CD45 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-CD45 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-CD45 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BosterBio
Novus Biologicals
Bio-Rad
MyBioSource
Leica Biosystems
Biorbyt
Thermo Fisher Scientific
R&D Systems
GeneTex
NSJ Bioreagents
Abcam
Bioss
CUSABIO Technology
LSBio
StressMarq Biosciences
BioLegend
Cell Signaling Technology
HUABIO
RayBiotech
Elabscience Bionovation
G Biosciences
Miltenyi Biotec
Beijing Solarbio Science & Technology
OriGene Technologies
American Research Products
SouthernBiotech
Tonbo Biosciences
Absolute Antibody
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-CD45 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-CD45 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global Anti-CD45 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-CD45 Antibody Market Perspective (2020-2031)
2.2 Global Anti-CD45 Antibody Growth Trends by Region
2.2.1 Global Anti-CD45 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-CD45 Antibody Historic Market Size by Region (2020-2025)
2.2.3 Anti-CD45 Antibody Forecasted Market Size by Region (2026-2031)
2.3 Anti-CD45 Antibody Market Dynamics
2.3.1 Anti-CD45 Antibody Industry Trends
2.3.2 Anti-CD45 Antibody Market Drivers
2.3.3 Anti-CD45 Antibody Market Challenges
2.3.4 Anti-CD45 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-CD45 Antibody Players by Revenue
3.1.1 Global Top Anti-CD45 Antibody Players by Revenue (2020-2025)
3.1.2 Global Anti-CD45 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global Anti-CD45 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-CD45 Antibody Revenue
3.4 Global Anti-CD45 Antibody Market Concentration Ratio
3.4.1 Global Anti-CD45 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-CD45 Antibody Revenue in 2024
3.5 Global Key Players of Anti-CD45 Antibody Head office and Area Served
3.6 Global Key Players of Anti-CD45 Antibody, Product and Application
3.7 Global Key Players of Anti-CD45 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-CD45 Antibody Breakdown Data by Type
4.1 Global Anti-CD45 Antibody Historic Market Size by Type (2020-2025)
4.2 Global Anti-CD45 Antibody Forecasted Market Size by Type (2026-2031)
5 Anti-CD45 Antibody Breakdown Data by Application
5.1 Global Anti-CD45 Antibody Historic Market Size by Application (2020-2025)
5.2 Global Anti-CD45 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-CD45 Antibody Market Size (2020-2031)
6.2 North America Anti-CD45 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-CD45 Antibody Market Size by Country (2020-2025)
6.4 North America Anti-CD45 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-CD45 Antibody Market Size (2020-2031)
7.2 Europe Anti-CD45 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-CD45 Antibody Market Size by Country (2020-2025)
7.4 Europe Anti-CD45 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-CD45 Antibody Market Size (2020-2031)
8.2 Asia-Pacific Anti-CD45 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-CD45 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-CD45 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-CD45 Antibody Market Size (2020-2031)
9.2 Latin America Anti-CD45 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-CD45 Antibody Market Size by Country (2020-2025)
9.4 Latin America Anti-CD45 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-CD45 Antibody Market Size (2020-2031)
10.2 Middle East & Africa Anti-CD45 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-CD45 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-CD45 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BosterBio
11.1.1 BosterBio Company Details
11.1.2 BosterBio Business Overview
11.1.3 BosterBio Anti-CD45 Antibody Introduction
11.1.4 BosterBio Revenue in Anti-CD45 Antibody Business (2020-2025)
11.1.5 BosterBio Recent Development
11.2 Novus Biologicals
11.2.1 Novus Biologicals Company Details
11.2.2 Novus Biologicals Business Overview
11.2.3 Novus Biologicals Anti-CD45 Antibody Introduction
11.2.4 Novus Biologicals Revenue in Anti-CD45 Antibody Business (2020-2025)
11.2.5 Novus Biologicals Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Anti-CD45 Antibody Introduction
11.3.4 Bio-Rad Revenue in Anti-CD45 Antibody Business (2020-2025)
11.3.5 Bio-Rad Recent Development
11.4 MyBioSource
11.4.1 MyBioSource Company Details
11.4.2 MyBioSource Business Overview
11.4.3 MyBioSource Anti-CD45 Antibody Introduction
11.4.4 MyBioSource Revenue in Anti-CD45 Antibody Business (2020-2025)
11.4.5 MyBioSource Recent Development
11.5 Leica Biosystems
11.5.1 Leica Biosystems Company Details
11.5.2 Leica Biosystems Business Overview
11.5.3 Leica Biosystems Anti-CD45 Antibody Introduction
11.5.4 Leica Biosystems Revenue in Anti-CD45 Antibody Business (2020-2025)
11.5.5 Leica Biosystems Recent Development
11.6 Biorbyt
11.6.1 Biorbyt Company Details
11.6.2 Biorbyt Business Overview
11.6.3 Biorbyt Anti-CD45 Antibody Introduction
11.6.4 Biorbyt Revenue in Anti-CD45 Antibody Business (2020-2025)
11.6.5 Biorbyt Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Anti-CD45 Antibody Introduction
11.7.4 Thermo Fisher Scientific Revenue in Anti-CD45 Antibody Business (2020-2025)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 R&D Systems
11.8.1 R&D Systems Company Details
11.8.2 R&D Systems Business Overview
11.8.3 R&D Systems Anti-CD45 Antibody Introduction
11.8.4 R&D Systems Revenue in Anti-CD45 Antibody Business (2020-2025)
11.8.5 R&D Systems Recent Development
11.9 GeneTex
11.9.1 GeneTex Company Details
11.9.2 GeneTex Business Overview
11.9.3 GeneTex Anti-CD45 Antibody Introduction
11.9.4 GeneTex Revenue in Anti-CD45 Antibody Business (2020-2025)
11.9.5 GeneTex Recent Development
11.10 NSJ Bioreagents
11.10.1 NSJ Bioreagents Company Details
11.10.2 NSJ Bioreagents Business Overview
11.10.3 NSJ Bioreagents Anti-CD45 Antibody Introduction
11.10.4 NSJ Bioreagents Revenue in Anti-CD45 Antibody Business (2020-2025)
11.10.5 NSJ Bioreagents Recent Development
11.11 Abcam
11.11.1 Abcam Company Details
11.11.2 Abcam Business Overview
11.11.3 Abcam Anti-CD45 Antibody Introduction
11.11.4 Abcam Revenue in Anti-CD45 Antibody Business (2020-2025)
11.11.5 Abcam Recent Development
11.12 Bioss
11.12.1 Bioss Company Details
11.12.2 Bioss Business Overview
11.12.3 Bioss Anti-CD45 Antibody Introduction
11.12.4 Bioss Revenue in Anti-CD45 Antibody Business (2020-2025)
11.12.5 Bioss Recent Development
11.13 CUSABIO Technology
11.13.1 CUSABIO Technology Company Details
11.13.2 CUSABIO Technology Business Overview
11.13.3 CUSABIO Technology Anti-CD45 Antibody Introduction
11.13.4 CUSABIO Technology Revenue in Anti-CD45 Antibody Business (2020-2025)
11.13.5 CUSABIO Technology Recent Development
11.14 LSBio
11.14.1 LSBio Company Details
11.14.2 LSBio Business Overview
11.14.3 LSBio Anti-CD45 Antibody Introduction
11.14.4 LSBio Revenue in Anti-CD45 Antibody Business (2020-2025)
11.14.5 LSBio Recent Development
11.15 StressMarq Biosciences
11.15.1 StressMarq Biosciences Company Details
11.15.2 StressMarq Biosciences Business Overview
11.15.3 StressMarq Biosciences Anti-CD45 Antibody Introduction
11.15.4 StressMarq Biosciences Revenue in Anti-CD45 Antibody Business (2020-2025)
11.15.5 StressMarq Biosciences Recent Development
11.16 BioLegend
11.16.1 BioLegend Company Details
11.16.2 BioLegend Business Overview
11.16.3 BioLegend Anti-CD45 Antibody Introduction
11.16.4 BioLegend Revenue in Anti-CD45 Antibody Business (2020-2025)
11.16.5 BioLegend Recent Development
11.17 Cell Signaling Technology
11.17.1 Cell Signaling Technology Company Details
11.17.2 Cell Signaling Technology Business Overview
11.17.3 Cell Signaling Technology Anti-CD45 Antibody Introduction
11.17.4 Cell Signaling Technology Revenue in Anti-CD45 Antibody Business (2020-2025)
11.17.5 Cell Signaling Technology Recent Development
11.18 HUABIO
11.18.1 HUABIO Company Details
11.18.2 HUABIO Business Overview
11.18.3 HUABIO Anti-CD45 Antibody Introduction
11.18.4 HUABIO Revenue in Anti-CD45 Antibody Business (2020-2025)
11.18.5 HUABIO Recent Development
11.19 RayBiotech
11.19.1 RayBiotech Company Details
11.19.2 RayBiotech Business Overview
11.19.3 RayBiotech Anti-CD45 Antibody Introduction
11.19.4 RayBiotech Revenue in Anti-CD45 Antibody Business (2020-2025)
11.19.5 RayBiotech Recent Development
11.20 Elabscience Bionovation
11.20.1 Elabscience Bionovation Company Details
11.20.2 Elabscience Bionovation Business Overview
11.20.3 Elabscience Bionovation Anti-CD45 Antibody Introduction
11.20.4 Elabscience Bionovation Revenue in Anti-CD45 Antibody Business (2020-2025)
11.20.5 Elabscience Bionovation Recent Development
11.21 G Biosciences
11.21.1 G Biosciences Company Details
11.21.2 G Biosciences Business Overview
11.21.3 G Biosciences Anti-CD45 Antibody Introduction
11.21.4 G Biosciences Revenue in Anti-CD45 Antibody Business (2020-2025)
11.21.5 G Biosciences Recent Development
11.22 Miltenyi Biotec
11.22.1 Miltenyi Biotec Company Details
11.22.2 Miltenyi Biotec Business Overview
11.22.3 Miltenyi Biotec Anti-CD45 Antibody Introduction
11.22.4 Miltenyi Biotec Revenue in Anti-CD45 Antibody Business (2020-2025)
11.22.5 Miltenyi Biotec Recent Development
11.23 Beijing Solarbio Science & Technology
11.23.1 Beijing Solarbio Science & Technology Company Details
11.23.2 Beijing Solarbio Science & Technology Business Overview
11.23.3 Beijing Solarbio Science & Technology Anti-CD45 Antibody Introduction
11.23.4 Beijing Solarbio Science & Technology Revenue in Anti-CD45 Antibody Business (2020-2025)
11.23.5 Beijing Solarbio Science & Technology Recent Development
11.24 OriGene Technologies
11.24.1 OriGene Technologies Company Details
11.24.2 OriGene Technologies Business Overview
11.24.3 OriGene Technologies Anti-CD45 Antibody Introduction
11.24.4 OriGene Technologies Revenue in Anti-CD45 Antibody Business (2020-2025)
11.24.5 OriGene Technologies Recent Development
11.25 American Research Products
11.25.1 American Research Products Company Details
11.25.2 American Research Products Business Overview
11.25.3 American Research Products Anti-CD45 Antibody Introduction
11.25.4 American Research Products Revenue in Anti-CD45 Antibody Business (2020-2025)
11.25.5 American Research Products Recent Development
11.26 SouthernBiotech
11.26.1 SouthernBiotech Company Details
11.26.2 SouthernBiotech Business Overview
11.26.3 SouthernBiotech Anti-CD45 Antibody Introduction
11.26.4 SouthernBiotech Revenue in Anti-CD45 Antibody Business (2020-2025)
11.26.5 SouthernBiotech Recent Development
11.27 Tonbo Biosciences
11.27.1 Tonbo Biosciences Company Details
11.27.2 Tonbo Biosciences Business Overview
11.27.3 Tonbo Biosciences Anti-CD45 Antibody Introduction
11.27.4 Tonbo Biosciences Revenue in Anti-CD45 Antibody Business (2020-2025)
11.27.5 Tonbo Biosciences Recent Development
11.28 Absolute Antibody
11.28.1 Absolute Antibody Company Details
11.28.2 Absolute Antibody Business Overview
11.28.3 Absolute Antibody Anti-CD45 Antibody Introduction
11.28.4 Absolute Antibody Revenue in Anti-CD45 Antibody Business (2020-2025)
11.28.5 Absolute Antibody Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-CD45 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global Anti-CD45 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Anti-CD45 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti-CD45 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Anti-CD45 Antibody Market Share by Region (2020-2025)
Table 8. Global Anti-CD45 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Anti-CD45 Antibody Market Share by Region (2026-2031)
Table 10. Anti-CD45 Antibody Market Trends
Table 11. Anti-CD45 Antibody Market Drivers
Table 12. Anti-CD45 Antibody Market Challenges
Table 13. Anti-CD45 Antibody Market Restraints
Table 14. Global Anti-CD45 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Anti-CD45 Antibody Market Share by Players (2020-2025)
Table 16. Global Top Anti-CD45 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD45 Antibody as of 2024)
Table 17. Ranking of Global Top Anti-CD45 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti-CD45 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Anti-CD45 Antibody, Headquarters and Area Served
Table 20. Global Key Players of Anti-CD45 Antibody, Product and Application
Table 21. Global Key Players of Anti-CD45 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-CD45 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Anti-CD45 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global Anti-CD45 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Anti-CD45 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global Anti-CD45 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Anti-CD45 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global Anti-CD45 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Anti-CD45 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America Anti-CD45 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Anti-CD45 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Anti-CD45 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Anti-CD45 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Anti-CD45 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Anti-CD45 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Anti-CD45 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Anti-CD45 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Anti-CD45 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-CD45 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Anti-CD45 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Anti-CD45 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Anti-CD45 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Anti-CD45 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Anti-CD45 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. BosterBio Company Details
Table 47. BosterBio Business Overview
Table 48. BosterBio Anti-CD45 Antibody Product
Table 49. BosterBio Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 50. BosterBio Recent Development
Table 51. Novus Biologicals Company Details
Table 52. Novus Biologicals Business Overview
Table 53. Novus Biologicals Anti-CD45 Antibody Product
Table 54. Novus Biologicals Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 55. Novus Biologicals Recent Development
Table 56. Bio-Rad Company Details
Table 57. Bio-Rad Business Overview
Table 58. Bio-Rad Anti-CD45 Antibody Product
Table 59. Bio-Rad Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 60. Bio-Rad Recent Development
Table 61. MyBioSource Company Details
Table 62. MyBioSource Business Overview
Table 63. MyBioSource Anti-CD45 Antibody Product
Table 64. MyBioSource Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 65. MyBioSource Recent Development
Table 66. Leica Biosystems Company Details
Table 67. Leica Biosystems Business Overview
Table 68. Leica Biosystems Anti-CD45 Antibody Product
Table 69. Leica Biosystems Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 70. Leica Biosystems Recent Development
Table 71. Biorbyt Company Details
Table 72. Biorbyt Business Overview
Table 73. Biorbyt Anti-CD45 Antibody Product
Table 74. Biorbyt Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 75. Biorbyt Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Anti-CD45 Antibody Product
Table 79. Thermo Fisher Scientific Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. R&D Systems Company Details
Table 82. R&D Systems Business Overview
Table 83. R&D Systems Anti-CD45 Antibody Product
Table 84. R&D Systems Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 85. R&D Systems Recent Development
Table 86. GeneTex Company Details
Table 87. GeneTex Business Overview
Table 88. GeneTex Anti-CD45 Antibody Product
Table 89. GeneTex Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 90. GeneTex Recent Development
Table 91. NSJ Bioreagents Company Details
Table 92. NSJ Bioreagents Business Overview
Table 93. NSJ Bioreagents Anti-CD45 Antibody Product
Table 94. NSJ Bioreagents Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 95. NSJ Bioreagents Recent Development
Table 96. Abcam Company Details
Table 97. Abcam Business Overview
Table 98. Abcam Anti-CD45 Antibody Product
Table 99. Abcam Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 100. Abcam Recent Development
Table 101. Bioss Company Details
Table 102. Bioss Business Overview
Table 103. Bioss Anti-CD45 Antibody Product
Table 104. Bioss Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 105. Bioss Recent Development
Table 106. CUSABIO Technology Company Details
Table 107. CUSABIO Technology Business Overview
Table 108. CUSABIO Technology Anti-CD45 Antibody Product
Table 109. CUSABIO Technology Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 110. CUSABIO Technology Recent Development
Table 111. LSBio Company Details
Table 112. LSBio Business Overview
Table 113. LSBio Anti-CD45 Antibody Product
Table 114. LSBio Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 115. LSBio Recent Development
Table 116. StressMarq Biosciences Company Details
Table 117. StressMarq Biosciences Business Overview
Table 118. StressMarq Biosciences Anti-CD45 Antibody Product
Table 119. StressMarq Biosciences Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 120. StressMarq Biosciences Recent Development
Table 121. BioLegend Company Details
Table 122. BioLegend Business Overview
Table 123. BioLegend Anti-CD45 Antibody Product
Table 124. BioLegend Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 125. BioLegend Recent Development
Table 126. Cell Signaling Technology Company Details
Table 127. Cell Signaling Technology Business Overview
Table 128. Cell Signaling Technology Anti-CD45 Antibody Product
Table 129. Cell Signaling Technology Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 130. Cell Signaling Technology Recent Development
Table 131. HUABIO Company Details
Table 132. HUABIO Business Overview
Table 133. HUABIO Anti-CD45 Antibody Product
Table 134. HUABIO Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 135. HUABIO Recent Development
Table 136. RayBiotech Company Details
Table 137. RayBiotech Business Overview
Table 138. RayBiotech Anti-CD45 Antibody Product
Table 139. RayBiotech Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 140. RayBiotech Recent Development
Table 141. Elabscience Bionovation Company Details
Table 142. Elabscience Bionovation Business Overview
Table 143. Elabscience Bionovation Anti-CD45 Antibody Product
Table 144. Elabscience Bionovation Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 145. Elabscience Bionovation Recent Development
Table 146. G Biosciences Company Details
Table 147. G Biosciences Business Overview
Table 148. G Biosciences Anti-CD45 Antibody Product
Table 149. G Biosciences Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 150. G Biosciences Recent Development
Table 151. Miltenyi Biotec Company Details
Table 152. Miltenyi Biotec Business Overview
Table 153. Miltenyi Biotec Anti-CD45 Antibody Product
Table 154. Miltenyi Biotec Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 155. Miltenyi Biotec Recent Development
Table 156. Beijing Solarbio Science & Technology Company Details
Table 157. Beijing Solarbio Science & Technology Business Overview
Table 158. Beijing Solarbio Science & Technology Anti-CD45 Antibody Product
Table 159. Beijing Solarbio Science & Technology Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 160. Beijing Solarbio Science & Technology Recent Development
Table 161. OriGene Technologies Company Details
Table 162. OriGene Technologies Business Overview
Table 163. OriGene Technologies Anti-CD45 Antibody Product
Table 164. OriGene Technologies Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 165. OriGene Technologies Recent Development
Table 166. American Research Products Company Details
Table 167. American Research Products Business Overview
Table 168. American Research Products Anti-CD45 Antibody Product
Table 169. American Research Products Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 170. American Research Products Recent Development
Table 171. SouthernBiotech Company Details
Table 172. SouthernBiotech Business Overview
Table 173. SouthernBiotech Anti-CD45 Antibody Product
Table 174. SouthernBiotech Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 175. SouthernBiotech Recent Development
Table 176. Tonbo Biosciences Company Details
Table 177. Tonbo Biosciences Business Overview
Table 178. Tonbo Biosciences Anti-CD45 Antibody Product
Table 179. Tonbo Biosciences Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 180. Tonbo Biosciences Recent Development
Table 181. Absolute Antibody Company Details
Table 182. Absolute Antibody Business Overview
Table 183. Absolute Antibody Anti-CD45 Antibody Product
Table 184. Absolute Antibody Revenue in Anti-CD45 Antibody Business (2020-2025) & (US$ Million)
Table 185. Absolute Antibody Recent Development
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
Table 189. Authors List of This Report


List of Figures
Figure 1. Anti-CD45 Antibody Picture
Figure 2. Global Anti-CD45 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-CD45 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibody Features
Figure 5. Polyclonal Antibody Features
Figure 6. Global Anti-CD45 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti-CD45 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology Case Studies
Figure 9. Medical Case Studies
Figure 10. University Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-CD45 Antibody Report Years Considered
Figure 13. Global Anti-CD45 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Anti-CD45 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti-CD45 Antibody Market Share by Region: 2024 VS 2031
Figure 16. Global Anti-CD45 Antibody Market Share by Players in 2024
Figure 17. Global Top Anti-CD45 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-CD45 Antibody as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Anti-CD45 Antibody Revenue in 2024
Figure 19. North America Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Anti-CD45 Antibody Market Share by Country (2020-2031)
Figure 21. United States Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti-CD45 Antibody Market Share by Country (2020-2031)
Figure 25. Germany Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti-CD45 Antibody Market Share by Region (2020-2031)
Figure 33. China Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti-CD45 Antibody Market Share by Country (2020-2031)
Figure 41. Mexico Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti-CD45 Antibody Market Share by Country (2020-2031)
Figure 45. Turkey Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Anti-CD45 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. BosterBio Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 49. Novus Biologicals Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 50. Bio-Rad Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 51. MyBioSource Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 52. Leica Biosystems Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 53. Biorbyt Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 55. R&D Systems Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 56. GeneTex Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 57. NSJ Bioreagents Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 58. Abcam Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 59. Bioss Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 60. CUSABIO Technology Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 61. LSBio Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 62. StressMarq Biosciences Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 63. BioLegend Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 64. Cell Signaling Technology Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 65. HUABIO Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 66. RayBiotech Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 67. Elabscience Bionovation Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 68. G Biosciences Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 69. Miltenyi Biotec Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 70. Beijing Solarbio Science & Technology Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 71. OriGene Technologies Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 72. American Research Products Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 73. SouthernBiotech Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 74. Tonbo Biosciences Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 75. Absolute Antibody Revenue Growth Rate in Anti-CD45 Antibody Business (2020-2025)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies